000 02457 a2200745 4500
005 20250517111225.0
264 0 _c20170905
008 201709s 0 0 eng d
022 _a1435-5922
024 7 _a10.1007/s00535-016-1245-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aToyota, Joji
245 0 0 _aDaclatasvir/asunaprevir/beclabuvir fixed-dose combination in Japanese patients with HCV genotype 1 infection.
_h[electronic resource]
260 _bJournal of gastroenterology
_cMar 2017
300 _a385-395 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntiviral Agents
_xadministration & dosage
650 0 4 _aBenzazepines
_xadministration & dosage
650 0 4 _aCarbamates
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Administration Schedule
650 0 4 _aDrug Combinations
650 0 4 _aFemale
650 0 4 _aGenotype
650 0 4 _aHepacivirus
_xgenetics
650 0 4 _aHepatitis C, Chronic
_xcomplications
650 0 4 _aHumans
650 0 4 _aImidazoles
_xadministration & dosage
650 0 4 _aIndoles
_xadministration & dosage
650 0 4 _aIsoquinolines
_xadministration & dosage
650 0 4 _aLiver Cirrhosis
_xvirology
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPyrrolidines
650 0 4 _aRNA, Viral
_xblood
650 0 4 _aSulfonamides
_xadministration & dosage
650 0 4 _aSustained Virologic Response
650 0 4 _aTreatment Outcome
650 0 4 _aValine
_xanalogs & derivatives
700 1 _aKarino, Yoshiyasu
700 1 _aSuzuki, Fumitaka
700 1 _aIkeda, Fusao
700 1 _aIdo, Akio
700 1 _aTanaka, Katsuaki
700 1 _aTakaguchi, Koichi
700 1 _aNaganuma, Atsushi
700 1 _aTomita, Eiichi
700 1 _aChayama, Kazuaki
700 1 _aFujiyama, Shigetoshi
700 1 _aInada, Yukiko
700 1 _aYoshiji, Hitoshi
700 1 _aWatanabe, Hideaki
700 1 _aIshikawa, Hiroki
700 1 _aHu, Wenhua
700 1 _aMcPhee, Fiona
700 1 _aLinaberry, Misti
700 1 _aYin, Philip D
700 1 _aSwenson, Eugene Scott
700 1 _aKumada, Hiromitsu
773 0 _tJournal of gastroenterology
_gvol. 52
_gno. 3
_gp. 385-395
856 4 0 _uhttps://doi.org/10.1007/s00535-016-1245-6
_zAvailable from publisher's website
999 _c26307896
_d26307896